AU2017245390B2 - Beverage cartridge containing pharmaceutical actives - Google Patents

Beverage cartridge containing pharmaceutical actives Download PDF

Info

Publication number
AU2017245390B2
AU2017245390B2 AU2017245390A AU2017245390A AU2017245390B2 AU 2017245390 B2 AU2017245390 B2 AU 2017245390B2 AU 2017245390 A AU2017245390 A AU 2017245390A AU 2017245390 A AU2017245390 A AU 2017245390A AU 2017245390 B2 AU2017245390 B2 AU 2017245390B2
Authority
AU
Australia
Prior art keywords
child
lidding
cartridge
another example
resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2017245390A
Other versions
AU2017245390A1 (en
Inventor
Kurt Franklin Trombley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to AU2017245390A priority Critical patent/AU2017245390B2/en
Publication of AU2017245390A1 publication Critical patent/AU2017245390A1/en
Application granted granted Critical
Publication of AU2017245390B2 publication Critical patent/AU2017245390B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00Containers, packaging elements or packages, specially adapted for particular articles or materials
    • B65D85/70Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
    • B65D85/804Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
    • B65D85/8043Packages adapted to allow liquid to pass through the contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/002Compounding apparatus specially for enteral or parenteral nutritive solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1406Septums, pierceable membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2027Separating means having frangible parts

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Packages (AREA)
  • Apparatus For Making Beverages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)

Abstract

A child-resistant cartridge adapted to be used with an automatic brewing machine. The cartridge has a base and a lidding. The base can contain a pharmaceutical active. The lidding can be a multilayer laminate with an outer layer and an inner layer. The cartridge can be made out of tear resistant materials that are sufficient to prevent 70% of children from accessing the contents of three or more cartridges during a Child-Resistant Screening Test. Fig 1

Description

BEVERAGE CARTRIDGE CONTAINING PHARMACEUTICAL ACTIVES
The present application is a divisional application from Australian patent application number 2014354787, the entire disclosure of which is incorporated herein by reference.
FIELD OF THE INVENTION
The present invention is related to a beverage cartridge and more particularly, a cartridge that is adapted to make beverages containing pharmaceutical actives.
BACKGROUND OF THE INVENTION
Currently, there are a number of cartridges for use in automatic brewing machines that make a single serving of a beverage product, such as coffee or tea. However, current cartridges are not suitable for use with pharmaceutical actives because the actives are sensitive to environmental conditions, such as humidity and oxygen, and the actives can degrade in current cartridges. Furthermore, the Consumer Product Safety Commission (CPSC) requires the primary package is child-resistant if the cartridge contains certain active ingredients, such as acetaminophen and diphenhydramine.
As such, there remains a need for a cartridge which is adapted for use in an automatic brewing machine that is both child-resistant and provides a barrier from environmental conditions to provide long term stability for pharmaceutical actives.
SUMMARY OF THE INVENTION
A child-resistant cartridge adapted to fit an automatic brewing machine comprising: (a) a base wherein the base contains a pharmaceutical active; and (b) a lidding wherein the lidding comprises a multilayer laminate comprising an outer layer and an inner layer; wherein the cartridge is made of tear resistant materials sufficient to prevent 70% of children from accessing the contents of five or more cartridges during a Child-Resistant Screening Test.
A child-resistant multi-layer laminate lidding adapted for a cartridge comprising: (a) an outer layer; and (b) an inner layer; wherein the lidding is made of tear resistant materials sufficient to prevent 70% of children from accessing the contents of five or more cartridges by puncturing the lidding during a Child-Resistant Screening Test and wherein the lidding is penetrable by a needle or other penetrator of an automatic brewing machine.
la
2017245390 30 Jan 2019
According to one embodiment, the present invention provides a child-resistant multilayer laminate lidding adapted for a cartridge comprising:
a. an outer layer; and
b. a second layer;
wherein the lidding is made of tear resistant materials sufficient to prevent 70% of children from accessing the contents of three or more cartridges by puncturing the lidding during a Child-Resistant Screening Test and wherein the lidding is penetrable by a needle or other penetrator of an automatic brewing machine.
According to one aspect, the present invention provides a child-resistant multi-layer laminate lidding adapted for a cartridge comprising:
a. a PET outer layer;
b. a foil second layer; and
c. a LLDPE inner layer;
wherein at least the PET outer layer of the lidding is made of a tear resistant material that is sufficient to prevent 70% of children from accessing the contents of three or more cartridges by puncturing the lidding during a Child-Resistant Screening Test, as herein defined, and wherein the lidding is penetrable by a needle or other penetrator of an automatic brewing machine.
A child-resistant cartridge adapted to fit an automatic brewing machine comprising: (a) a base wherein the base contains a pharmaceutical active; and (b) a lidding; wherein the cartridge is made of tear resistant materials sufficient to prevent 70% of children from accessing the contents of five or more cartridges during a Child-Resistant Screening Test.
Throughout the description and claims of the specification, the word comprise and variations of the word, such as comprising and comprises, is not intended to exclude other additives, components, integers or steps.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a three-dimensional exploded view of a beverage cartridge;
FIG. 2 is a side sectional view of a beverage cartridge of FIG. 1;
FIG. 3 is a side sectional view of a lidding for a beverage cartridge;
FIG. 4A is a lidding for a beverage cartridge;
FIG. 4B is a lidding for a beverage cartridge;
FIG. 5 is a side sectional view of a beverage cartridge with two compartments;
FIG. 6 is an example of a side sectional view of a beverage cartridge with two chambers; and
FIG. 7 is an example three-dimensional exploded view of a beverage cartridge with a 0 filter.
DETAILED DESCRIPTION OF THE INVENTION
Many consumers enjoy drinking hot or cold beverages with pharmaceutical actives. A convenient and easy way to make a single serving of a hot or cold beverage is to use an 5 automatic brewing machine with a cartridge. However, the current cartridges are not adapted to be used with pharmaceutical actives for two reasons. First, the current cartridge does not provide a sufficient barrier to environmental conditions to prevent degradation. Second, the current cartridges are not child-resistant. It has been observed that children are able to open the current cartridges with their teeth and then using their fingers to peel off the lidding to access the 20 contents or by applying pressure to the lidding with their thumb to puncture the lidding.
Furthermore, once a child figured out how to open one cartridge, he was able to quickly open additional cartridges.
The cartridges of the present invention can provide a sufficient barrier from environmental conditions including humidity and gases, including oxygen, and can be child25 resistant. The structure and/or material(s) of the base and/or the lidding can provide long term stability for the pharmaceutical actives and/or child-resistance. The cartridge can have a base and a lidding structure. In one example, the base can be a multi-layer laminate, which can include polychlorotrifluoroethylene (PCTFE), an adhesive, and polyethylene terephthalate with a glycol modifier (PETG). In another example, the lidding can be a multi-layer laminate structure that can 30 comprise aluminum foil, adhesive, and a plastic. The base and/or the lidding can be tear resistant.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
Furthermore, while being child-resistant, the bottom of the base and/or the lidding can still be penetrable by a needle or penetrator of the automatic brewing machine.
The cartridge can meet the definition of child-resistant under the U.S. Poison Prevention Packaging Act of 1970 (16 C.F.R. §1700.14). Specifically, the cartridges can meet the definition 5 of F=3 according to the Child-Resistant Testing as described herein. In another example, the cartridge can meet the definition of F=1 according to the Child-Resistant Testing, in another example F=2, in another example F=4, in another example F=5, and in another example F=6. In one example, the cartridge alone meets the definition of child-resistant without the secondary packaging.
The cartridge can be adapted for use in an automatic machine such as a single serving automatic brewing machine. Some of these machines can have a penetrator or needle that can penetrate the lidding and then provide a flow of water, frequently hot water, through the hole in the lidding, while a second penetrator or needle pushes through the bottom of the base to receive the outflow of the beverage and dispense it into a cup or container. Even though the base and the lidding layer are child resistant, in some examples, they can be penetrated by a penetrator or needle of a brewing machine. In another example, the child-resistant and/or barrier features do not interfere with normal operation of the automatic brewing machine.
As used herein, “active” or “pharmaceutical active” includes all compounds and compositions that can be used to treat and/or prevent illness and/or provide overall health and Ό wellness benefits in mammals, particularly humans. Non-limiting examples of particularly useful actives include over-the-counter (OTC) actives, behind the counter actives, and prescription actives, vitamins, minerals, plant-derived materials, energy boosting materials, probiotics, fiber, prebiotics, and combinations thereof.
As used herein, “child-resistant” means a cartridge or other packaging that is designed or constructed to be significantly difficult for young children to open or obtain a toxic or harmful amount of the substance contained therein within a reasonable time and not difficult for normal adults to use properly, but does not mean packaging which all such children cannot open or obtain a toxic or harmful amount within a reasonable time.
As used herein, “dissolve” refers to passing into solution.
As used herein, “disintegrate” refers to breaking up into small parts.
As used herein, “permanently joined” refers to configurations in which a first element is secured to a second element such that the elements generally cannot be separated from one another without at least partially destroying one or both of the elements.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
As used herein, “primary packaging” refers a packaging component that is or may be in direct contact with the dosage form.
As used herein, “releasably joined” refers to configurations in which a first element is secured to a second element, such that the first element and the second element can be separated 5 with no or minimal damage to the first and second elements.
As used herein, “tear resistant” means capable of experiencing a reasonable level of stress and/or deformation without experiencing a significant loss of integrity. Stress and/or deformation can be applied by a number of movements including, but not limited to, biting, pulling, pealing, poking, pushing and/or jabbing at the cartridge. In one example, any of these movements can be 0 performed by a child, and tear resistant refers to a material that is capable of experiencing a reasonable level of stress and/or deformation without experiencing a significant loss of integrity when undergoing forces that can be applied by a child. In one example, the child is six years or younger, in another example five years or younger, in another example four years or younger, in another example three or younger, in another example two or younger, and in another example 5 18 months or younger. In one example, even though the cartridge is tear resistant, it can still be punctured with the needle or penetrator of an automatic brewing machine.
As used herein, the term “treat” or “treating” includes preventing, alleviating, ameliorating, inhibiting, or mitigating one or more health conditions in a mammal, in particular a human and in one example an adult human. Non-limiting examples of health conditions can Ό include respiratory conditions.
As used herein, the articles “a” and “an” are understood to mean one or more of the material that is claimed or described, for example, an active or a compartment.
FIG. 1 shows an exploded view of cartridge 1 and FIG. 2 shows a side sectional view of cartridge 1. Cartridge 1 includes base 10 and lidding 20. Base 10 includes opening 11 and 25 outwardly facing rim 13. Base 10 can have the shape of a cup, cylinder, bowl, or an inverted truncated cone. Base 10 can include component 12, which can include an active and/or an excipient. In one example, the component can be a powder. Bottom 15 of base 10 can be penetrable by a penetrator or needle during use.
With reference to FIG. 2, inner surface 26 of lidding 20 can be permanently joined to rim 30 13 of base 10 at seal 25. The lidding can be joined to the base by any suitable method. In one example, the lidding has a coating that is heat activated, causing it to attach to the rim of the base when exposed to heat. In another example, the lidding can be attached using ultrasonic frequency
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017 and in another example the lidding can be attached using induction heating. Alternatively, the lidding can be attached with a contact adhesive.
Lidding 20 can be a child-resistant laminate with outer layer 21 and inner layer 22. Outer layer 21 can provide the child-resistance and can be tear resistant while still be penetrable by a 5 needle or other penetrator of an automatic brewing machine. In one example, outer layer 21 can contain reinforced strands 24, which can provide additional child resistance. Reinforced strands 24 can form a mesh across lidding 20 and in one example, the mesh can be open at the location where the lidding is intended to be punctured by a needle or penetrator. In one example, the reinforced strands can be embedded in the child-resistant laminate. In another example, the 0 reinforced strands are underneath the outer layer. In another example, the reinforced strands can be underneath the inner layer. In another example, the reinforced strands can be between the outer layer and the inner layer. In another example, the reinforced strands can be embedded in the outer layer and/or the inner layer. The reinforced strands can be made of any suitable material including nylon, polypropylene, fiberglass, and combinations thereof.
Inner layer 22 can reduce the amount of gasses, including oxygen, from entering cartridge
1. Inner layer 22 can be made out of any suitable material and in one example, inner layer 22 can be made out of aluminum foil. Inner layer 22 can be opaque which can provide additional childresistance. In another example, inner layer 22 can also include ink. In one example, outer layer 21 and inner layer 22 are permanently joined by an adhesive.
Ό The lidding can be both child-resistant and provide an adequate barrier from gasses and humidity, while still being penetrable by a needle or other penetrator of an automatic brewing machine. In one example, the lidding is a laminate. The laminate can have any number of layers. In one example the laminate has at least two layers, in another example at least three layers, in another example at least four layers, and in another example at least five layers. In another 25 example, the lidding can be only one layer. In one example, one or more layers of the lidding can be opaque and in another example one or more layers of the lidding can be transparent.
FIG. 3 is an example of a side sectional view of lidding 30 for a beverage cartridge. Lidding 30 can comprise outer layer 32, second layer 33, third layer 34, and inner layer 35. In one example, outer layer 32 can comprise polyethylene terephthalate (PET), second layer 33 can 30 comprise orientated polyamide (OPA), third layer 34 can comprise aluminum, and inner layer 35 can comprise polyethylene vinyl acetate (PE-EVA). In another example, inner layer 35 can comprise linear low-density polyethylene (LLDPE). In one example, each layer is attached to an adjacent layer with an adhesive. In another example, ink is between the outer layer and the
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017 second layer. In another example, ink is printed on the outer layer. In another example, a heat seal coating partially or entirely covers the inner layer.
FIGS. 4A and 4B are examples of liddings with weakened areas. The weakened area can be in the region that is intended to be punctured by a needle or other penetrator of an automatic 5 brewing machine. This weakened area can allow the lidding to be child resistant while still allowing the lid to be penetrated by a needle or penetrator. The weakened area can extend partially or completely through one or more layers of the laminate lidding. In one example, the weakened area is on the outer layer of the lidding. In another example, the weakened area is not on the outer layer of the lidding because a child could see the weakened area and gain access or 0 pick and peel at an edge of the weakened area. In one example, the weakened area does not penetrate the inner layer. In another example, the weakened area only penetrates or partially penetrates the outer layer. In one example, the weakened can be small enough so it is difficult for a child to use it to access the cartridge contents. In one example, the weakened area is from about 1 mm to about 12 mm at its widest point, in another example from about 2 mm to about 10 mm, 5 and in another example from about 3 mm to about 8 mm.
FIG. 4A is an example of lidding 40 with a weakened area, hole 42. The hole can be any suitable shape. Non-limiting examples of shapes can include a circle, square, diamond, rectangle, triangle, star, cross, oval, and combinations thereof.
FIG. 4B is an example of lidding 45 with a weakened area, scored portion 47. Scored Ό portion 47 can be in any of the shapes listed above, as well as an “x”, cross-hatching, multiple dots, and combinations thereof.
FIG. 5 is an example of a side sectional view of beverage cartridge 5 with more than one compartment. For some components it could be advantageous to separate some of the ingredients until immediately before they are consumed. In one example, the actives and/or excipients are 25 incompatible and separating them prolongs the stability of the components. In another example, the components are in different states, for example one component is a solid and the other is a liquid. In another example, one compartment contains a component with an active and another compartment contains a component with a flavor, which could allow for more robust flavor delivery, particularly if the flavor was a liquid.
In FIG. 5, beverage cartridge 5 has first compartment 51 containing first component 53 and second compartment 52 containing second component 54. First compartment 51 and second compartment 52 are separated by divider 55.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
The divider can be any suitable material. In one example the divider partially or completely dissolves or partially or completely disintegrates, when exposed to hot or cold water. In another example, the divider can be a mesh or woven material that separates the components when they are solid but when the components dissolve in water, the solution can travel through 5 the mesh or woven material. In another example, the divider can be punctured with the needle or penetrator from the automatic brewing machine. When the divider is punctured, water and the second component can flow from the second compartment to the first compartment.
The beverage cartridge can have multiple compartments. In one example, the beverage cartridge can have at least two compartments, in another example at least three compartments, 0 and in another example at least four compartments. The compartments can extend in any direction including horizontally across the cartridge, vertically from the bottom of the base to the lidding, diagonally, or combinations thereof.
FIG. 6 is an example of side sectional view of beverage cartridge 6 with multiple chambers. Cartridge 6 has first chamber 61 containing first component 63 and second chamber 5 62 containing second component 64. The chambers not only can keep the components separate until just before use but they can also allow the user to select which actives she wants in her beverage.
In one example, the automatic brewing machine can have an upper needle 66, which punctures lidding 65, approximately in the center, and does not puncture first chamber 61 or Ό second chamber 62. Simultaneously, lower needle 67 punctures the bottom 68 of base 69 and chamber 63. Lower needle 67 does not puncture the middle of base 67, instead it punctures off center. Thus by arranging cartridge 6 with a particular orientation in the brewing machine, one chamber could be broken, while the other chamber remains intact. In one example, the chambers can be made of a frangible material and/or can be pre-scored so when the lower needle punctures 25 the chamber it cracks or breaks completely in two or more parts. Non-limiting examples of frangible materials can include starch based films, water soluble modified cellulose films such as hydroxyethyl cellylose, ethyl vinyl acetate films, and combinations thereof. When the brewing begins, water will flow out the upper needle and flow around the intact chamber, while combining with the components of the broken chamber and making a beverage with the desired 30 components.
For instance, the first chamber may contain an active to treat aches and pains, such as acetaminophen or ibuprofen, and the second chamber may contain an active to treat cough, such as dextromethorphan. If the consumer does not have a cough she can position the cartridge in the
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017 automatic beverage brewer such that only the chamber that has the actives for aches and pains is penetrated by the bottom needle. However, if the consumer wants both actives she can brew twice, puncturing both chambers.
In another example, the chamber can contain different flavors allowing the user to select a 5 flavor of her beverage.
In another example, the upper needle can puncture both chambers. The lower needle punctures only one chamber and liquid from the upper needle can flow into both chambers but the beverage will only be able to flow out of the chamber punctured by lower needle. Thus, the consumer can make a beverage with the desired components.
The cartridge can have any suitable number of chambers. In one example, the cartridge can have at least two chambers, in another example at least three chambers, and in another example at least four chambers. In one example, the cartridge could have a single chamber that could allow the consumer to make a beverage with just the component outside the chamber or with both components.
In another example, the chambers can be used to separate incompatible components.
FIG. 7 is an example of a cartridge 7 with a base 70, lidding 71, and a filter 72. Filter 72 contains component 73. The filter can be used when brewing a drink, such as coffee or tea. The water will seep through the filter and extract the essence of the components and the solid particles will be retained in the filter. In one example, the actives and/or other excipients can Ό dissolve into the water as it passes through the filter. In one example, the cartridge with a filter can be used to brew coffee or tea containing actives.
In one example, the cartridge does not contain a filter.
In another example, at least one of the ingredients are packaged in a separate container and added by the consumer, or person preparing the beverage for the consumer, before or after their beverage is brewed by the automatic brewing machine. In one example the ingredient can be a flavor and in another example the ingredient can contain one or more actives. In one example, the separate container can be a sachet. In one example, the separate container can contain a liquid. In another example the separate container can contain a solid, where the solid can be a powder, nonpareils, capsule, tablet, or combinations thereof. In another example, the consumer uses the automatic brewing system to puncture the top of the cartridge but before brewing the beverage the consumer reopens the machine and adds the separately packaged ingredient to the cartridge through the hole made by the automatic brewing machine and then recloses the machine and brews their beverage.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
The base can be made of any suitable material(s) that provide the desired barrier properties and child-resistance and can still be penetrated by the needle or penetrator of the automatic brewing machine. Non-limiting examples of materials that can be incorporated into the laminate material of the base can include high-density polyethylene (HDPE), cyclic olefin 5 copolymers (COC), biaxally orientated polyamide (OPA), polypropylene (PP), polyester (PET), amorphous polyethylene terephthalate (APET), polyvinyl chloride (PVC), polyethylene (PE), aluminum foil, and combinations thereof. In another example the laminate can include a polyvinylidene chloride coating and in another example the laminate can include ethylvinyl alcohol (EVOH). In one example, the base can be transparent and in another example the base 0 can be opaque.
In one example, the base can be a laminate made from polychlorotrifluoroethene (PCTFE), an optional adhesive, and polyethylene terepthalate glycol (PETG). In one example, the PETG can be from about 25 pm to about 1.5 mm thick, in another example from about 50 pm to about 1 mm, in another example from about 100 pm to about 500 pm, and in another example 5 from about 200 pm to about 300 pm. In another example, the PCTFE can be from about 10 pm to about 250 pm, in another example from about 25 pm to about 150 pm, in another example from about 30 pm to about 100 pm, and in another example from about 40 pm to about 75 pm.
In one example, the base can be a laminate with an inner layer and an outer layer. In one example, the inner layer can be EVOH, or another material that is difficult for a child to puncture or tear. The inner layer and the outer layer of the base can be releasably joined. When the child tries to open the container, for instance by puncturing, tearing, or biting, the inner layer can separate from the outer layer. This separation can slow the child down, which can give a parent or caregiver more time to intervene and prevent the child from accessing cartridges. This separation may also make the child feel like they are making progress getting the package open, when in reality delaminating these two layers is not contributing to gaining access to the component, since the child cannot break through the inner and/or outer layer.
In one example, the maximum thickness of the base material can be greater than the maximum thickness of current pharmaceutical product barrier materials, such as cavities on a 20 blister card, because the cartridge has dimensions larger than a typical pharmaceutical product enclosure. Using base material with a greater starting thickness provides for sufficient thickness when the base of the cartridge is formed because the material is stretched by a greater degree towards the bottom of the cartridge base.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
Current lidding can be removed by children with a combination of biting and scratching. Thus, the lidding can be tear resistant. In one example, the lidding is a multi-layer laminate. Nonlimiting examples of materials that can be incorporated into the laminate material of the lidding can include aluminum foil, PCTFE, EVOH, HDPE, OPA, COC, PP, PET, APET, PVC, PE, and 5 combinations thereof.
For both the laminate in the lidding layer and the base, the layers of the laminate can be affixed by an adhesive layer, which can comprise a polyolefin material like low density polyethylene (LDPE).
In one example, the laminate can have an outer layer, a second layer, and an inner layer. 0 The outer layer can be PET, the second layer can be foil, and the inner layer can be LLDPE.
In one example the outer layer or PET layer can be from about 5 pm to about 40 pm thick, in another example from about 10 pm to about 35 pm thick, in another example from about 15 pm to about 30 pm thick, and in another example from about 20 pm to about 25 pm thick. In one example the outer layer or PET layer can be greater than about 8 pm, in another example 5 greater than about 11 pm, in another example greater than about 16 pm, in another example greater than about 20 pm, and in another example greater than about 22 pm.
In another example, the second layer or foil layer can be from about 3 pm to about 30 pm, in another example from about 8 pm to about 25 pm thick, and in another example from about 15 pm to about 22 pm thick. In another example the second layer or foil layer can be Ό greater than about 5 pm thick, in another example greater than about 8 pm thick, in another example greater than about 12 pm thick, in another example greater than about 15 pm thick, and in another example greater than about 17 pm thick.
In another example, the inner layer or LLDPE layer can be from about 10 pm to about 40 pm thick, in another example from about 15 pm to about 35 pm thick, in another example from 25 about 20 pm to about 30 pm thick, and in another example from about 22 pm to about 27 pm thick. In another example, the inner layer or LLDPE layer can be greater than about 8 pm thick, in another example greater than about 13 pm thick, in another example greater than about 18 pm thick, in another example greater than about 20 pm thick, in another example greater than about 22 pm thick, and in another example greater than 24 pm thick.
The base, lidding, and/or cartridge can provide an effective barrier. In one example, the base, lidding, and/or cartridge can have a final moisture vapor transmission rate of about 2 x 10’5 to about 2 x 10’3 g/cartridge/day, in another example from about 1 x 10’4 to about 6 x 10’4 g/cartridge/day, and in another example from about 2 x 10-4 to about 3 x 10’4 g/cartridge/day, as
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017 determined by the United States Pharmacopeial (USP) <671> (August 1, 2013). Follow Method 1 of the procedure for Single-Unit Containers and Unit-Dose Containers for Capsules and Tablets.
The cartridge can provide long term stability to the pharmaceutical actives. In one example, the pharmaceutical active in the cartridge have a shelf life of at least about 1 year, in another example at least about 18 months, in another example at least about 2 years, and in another example at least about 2.5 years. As used herein, “shelf life” refers to the time period during which a drug product is expected to remain within the approved shelf life specification, provided that it is stored under the conditions defined on the container label. The conditions under which shelf life testing is conducted, the specific measurements and the minimum requirements for usable, fit for consumption or saleable can be set by governmental or regulatory bodies and can be published in guidance documents such as the United States Pharmacopeial (USP) or ICH Harmonised Tripartite Guideline Stability Testing of New Drug Substances and Products Q1A(R2), Step 4, of the version published February 6th, 2003.
In one example, the pharmaceutical active is at least about 90% of label for at least 1 year, in another example for at least about 1.5 years, in another example for at least about 2 years, and in another example for at least about 3 years. In another example the pharmaceutical active is at least about 95% of label for at least 1 year, alternatively at least about 1.5 years, alternatively at least about 2 years. The cartridge may provide long term stability by maintaining Ό the pharmaceutical active above about 80% or label for at least about 1 year, alternatively at least about 1.5 years, alternatively at least 2 years.
The cartridges can be in secondary packaging. In one example, the secondary package can be a standard paperboard box that contains from about 1 to about 12 cartridges, and in another example from about 3 to about 6 cartridges. In another example, the secondary package 25 can be child-resistant. In one example, the secondary package can contribute to the overall childresistance of the cartridge. In another example the secondary package can be an F=1 childresistant package, in another example an F=2 child-resistant package, and in another example an F=3 child-resistant package. In another example, each cartridge is individually packaged in a secondary package. In another example, the secondary packaging can provide additional barrier 30 properties to help prolong stability of the components.
In one example, the cartridge can be used with an automatic brewing machine and can be adapted to fit in an automatic brewing machine. In another example, the cartridge can be used without an automatic brewing machine.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
In one example, the cartridges are disposable which means that the cartridge can be disposed of or discarded after a limited number of uses. In one example, the cartridge can be used five or fewer times, in another example three or fewer times, in another example two or fewer times, and in another example the cartridge is used only one time. In another example, the 5 cartridge can be reused and can be refilled with a component containing an active and/or an excipient.
The component can include both one or more actives and/or one or more excipients. The component can be in any suitable form including, but not limited to, a powder, a liquid, a gel, or a tablet. Non-limiting example of excipients can include flavors, sweeteners, disintegrants, fillers, 0 colors, lubricants, glidants, sorbents, preservatives, sensates, and combinations thereof. In one example, the component is a powder that dissolves as the water passes through the cartridge. In another example, the component is a concentrated liquid that can be diluted when the water passes through the cartridge. In yet another example, the component is only partially dissolved or extracted to make the beverage.
The cartridge can contain one or more actives. In one example, the beverage containing actives can be consumed by adults and children 12 years and over. In another example, the beverage containing actives can be intended to be consumed by children, often under the supervision of an adult.
The actives can treat a variety of symptoms including, but not limited to, symptoms from Ό cold, flu, or allergies. Non-limiting examples of actives can include decongestants, expectorants, antihistamines, antitussives, pain relievers, and combinations thereof.
In one example, the cartridge can provide multi-symptom relief of cold and/or flu symptoms and can be intended for use at night. The cartridge can deliver about 650 mg acetaminophen, about 30 mg dextromethorphan HBr, about 10 mg of phenylephrine, about 30 to 25 about 60 mg of pseudoephedrine, and/or about 12.5 mg doxylamine succinate during a single brew cycle.
In some examples, how much active is delivered, does not necessarily mean that the cartridge contains this amount of active. The cartridge will likely contain more active than what is delivered to the user since in some examples, not all of the active will be transferred from the 30 cartridge to the beverage. Furthermore, according to government regulations, such as the USP, the delivered amount of active can be within 10% of the monographed amount.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
In another example, the cartridge can help relieve occasional sleeplessness and/or can help reduce the time to fall asleep if you have difficulty falling asleep. The cartridge can provide about 50 mg diphenhydramine HC1 or about 25 mg of doxylamine succinate.
In another example, the cartridge can help the user treat allergy symptoms. The cartridge can deliver about 25 mg to about 50 mg diphenhydramine HC1, about lOmg loratadine, about 650 mg to about 1000 mg acetaminophen, about 7.5 mg to about 12.5 mg doxylamine, and/or about 10 mg phenylephrine.
In another example, the cartridges can be sold in combination with other products, in particular products containing over-the-counter actives or vitamins and/or minerals. In one 0 example, the cartridge can contain actives intended for nighttime relief of cold and/or flu symptoms and the cartridge can be packaged or otherwise sold in combination with actives intended for daytime relief of cold and/or flu symptoms such as acetaminophen, dextromethorphan, and phenylephrine. In another example, the cartridge can contain vitamins, for instance a tea containing vitamins, and it can be packaged or otherwise sold in combination 5 with over-the-counter actives, for instance actives containing daytime and/or nighttime relief of cold and/or flu symptoms. The over-the-counter actives can be any dosage form including, but not limited to, a liquid, solid dosage forms such as liquicaps or tablets, or a cartridge.
The automatic brewing machine can dispense an entire dose of active as determined by the monograph. Thus, the active can quickly dissolve or can be extracted into water as it is being Ό brewed. In one example, the cartridge can contain more than the monographed dosage of the active in order to ensure that the correct dosage is in the consumer’s cup. The beverage can be any volume. In one example the beverage is from about 100 mL to about 500 mL, in another example from about 125 mL to about 250 mL, in another example from about 130 mL to about 250 mL, and in another example about 150 mL to about 200 mL. In one example, the beverage is 25 about 6 fluid ounces (177.41 mL) and in another example the beverage is about 8 fluid ounces (236.59 mL).
In one example, following each use the automatic brewing machine can be rinsed with water or otherwise cleaned to remove residual actives and/or excipients. Lor example, a brewing cycle can be conducted by the consumer without a cartridge in the machine. In one example, the 30 automatic brewing machine can be cleaned with water. In another example, the automatic brewing machine can be cleaned with a cleaning agent, for instance a cleaning agent comprising vinegar. Some consumers may also want to clean the brewing machine before brewing the beverage.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
In one example, the cartridge can be child-resistant and can be given a rating that is referred to as the F value. The F Value refers to the number of unit doses to which access is considered a test failure. The number following the “F” refers to the number of unit doses that may produce serious personal injury or serious illness based on a 25-pound (11.4 kg) child.
The Child-Resistant Test is a standardized test and can be found in 16 C.F.R. §1700
Poison Prevention Packaging. In one example, the child-resistant package is an F=1 package, in another example an F=2 package, in yet another example an F=3 package, in another example an F=4 package, and in yet another example an F=5 package.
In one example about 80% or more of the children in the child resistance test cannot access the contents of 5 cartridges or fewer, in another example about 70% or more of the children cannot the contents of 5 cartridges or fewer, in another example about 60% or more of the children cannot access the contents of 5 cartridges or fewer. In another example about 80% or more of the children in the child resistance test cannot access the contents of 4 cartridges or fewer, in another example about 70% or more of the children cannot access the contents of 4 cartridges or fewer, in another example about 60% or more of the children cannot access the contents of 4 cartridges or fewer. In another example, about 80% or more of the children in the child resistance test cannot access the contents of 3 cartridges or fewer, in another example about 70% or more of the children cannot access the contents of 3 cartridges or fewer, in another example about 60% or more of the children cannot access the contents of 3 cartridges or fewer.
Ό In another example, about 80% or more of the children in the child resistance test cannot access the contents of 2 cartridges or fewer, in another example about 70% or more of the children cannot access the contents of 2 cartridges or fewer, in another example about 60% or more of the children cannot access the contents of 2 cartridges or fewer.
Test Methods
Child-Resistant Testing
The child-resistant testing can be conducted according to the Code of Federal Regulations Title 16: Part 1700.
Child-Resistant Screening Test
The Child-Resistant Screening Test can be conducted as follows:
For the Child-Resistant Screening Test the children are between 42-51 months of age.
Both boys and girls are selected in approximately even numbers.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
A test failure is defined as any child who gains access to the cartridge contents. For the following experiment, the test was a failure if any child accessed the contents of three or more cartridges during the full 10 minutes of testing. As used herein, “gained access to” means that the actives have been removed or can be removed in whole or in part. In the case of a cartridge, the 5 active can be removed if any amount of active can spill out of the cartridge if it is inverted. If a cartridge or package is breached and the contents are not removed but could be removed, this is still considered access.
The children are tested two at a time. The two children are escorted to the test area and are seated so there is no physical barrier between the children and the tester. The tester will talk 0 to the children to make them at ease. The children are not given the impression that they are in a race or a contest, they are not offered a reward, and they are not told that the test is a game or that it is fun. To begin the test the tester shall hand the children identical cartridges and say “Please try and open this for me.” If the child refuses to participate after the test has started, the tester shall reassure the child and gently encourage the child to try. If the child continues to refuse, the 5 tester shall ask the child to hold the cartridge in his/her lap until the other child is finished. This pair of children shall not be eliminated from the results unless the refusing child disrupts the participation of the other child.
Each child will be given 5 minutes to open his/her cartridge. The tester shall minimize conversations with the children as long as they continue to attempt to open their packages. The Ό tester shall not discourage the children verbally or with facial expressions. If a child gets frustrated or bored and stops trying to open his/her cartridge, the tester shall reassure the child and gently encourage the child to keep trying. The children should be allowed freedom of movement to work on their cartridges as long as the tester can watch both children (e.g. they can stand up, get down on the floor, or bang or pry the package). The children shall be allowed to talk 25 to each other about opening the cartridges and shall be allowed to watch each other try to open packages. If the child opens his/her cartridge, the tester shall say, “Thank you,” and take the opened cartridge from the child and give the child another unopened cartridge.
At the end of the 5-minute period, the tester shall ask the children to put their cartridges down and then shall demonstrate how to open the cartridge. This demonstration is done by 30 performing a demonstration of how to use the cartridge in the machine, a Keurig® K75 Platinum Edition brewer. The children shall not be allowed to continue to try to open their cartridges during the demonstration period. The tester shall say, “watch me use this package.” Once the tester gets the children’s full attention, the tester shall hold the demo package approximately two
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017 feet from the children and open the package at a normal speed as if the tester were going to use the contents. There shall be no exaggerated opening movements. The tester shall not discuss or describe how to open the package. After opening the package, the tester shall show the children the package.
Then, the children are given a second five-minute period to try and open their cartridges.
The tester begins the five minute period by saying, “now you try to open your packages.” If both children have not used their teeth to try to open their packages during the first 5 minutes, the tester shall say immediately before or soon after beginning the second 5-minute period, “You can use your teeth if you want to.” This is the only statement that the tester shall make about using 0 teeth. The test shall continue for another five minutes or until both children have opened their packages, whichever comes first.
Example 1
Example 1 shows the results from the Child-Resistant Screening Test. The procedures for the Child-Resistant Screening Test were followed as described above. The trial used Swiss Miss K-Cups® (purchased at Keurig.com, on October 25th, 2013, lot number 6696 PL120, expiration date January 17, 2015). Table 1, below, shows how many cartridges were opened and how long it took to open each one. Table 2, describes how each of the cartridges that were opened was accessed.
Ό
Table 1
Gender Age (mo) First 5 min test period Time to open cartridge (min) Second 5 min test period Time to open cartridge (min)
1 2 3 4 5 6 1 2 3 4 5 6
1 Male 42
2 Female 43
3 Female 43
4 Male 45
5 Female 45
6 Male 46
Female 45 1:42 2:54 3:22 3:42 4:20 4:31 6:10
8 Female 49 4:30 6:29 6:43 7:04 7:14 7:24
9 Male 51 6:00 6:25 6:31 6:50 6:58 7:05
10 Female 49
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
11 Male 51
12* Male 50 5:58 6:57 7:38 9:12
13 Male 46
14 Female 42
15 Female 43
16 Female 43
17 Male 48 5:32 6:01 6:31 6:39 6:59 7:21
18 Male 50 5:21 5:46 6:01 6:13 6:32 7:16
19 Female 48 7:49 8:06 8:32 8:57 9:59 10:12
20 Male 43 7:00 7:36 8:07 8:32 9:19 10:00
21 Male 50
*Child was given a cartridge that had a reinforced top for second five minute test period. The top was reinforced with packing tape that was reinforced with fiber. The tape was adhered over the lidding of the Swiss Miss K-Cup® and a hotplate was used to further bond the tape to the lidding.
Table 2
Gender Age (mo) Description of how cartridges were opened during the first 5 min test period Description of how cartridges were opened during the second 5 min test period
Female 45 Child used teeth. Child was given a cartridge with reinforced tape for the second five minutes. Child peeled re-enforced tape and then used teeth.
8 Female 49 Child used teeth. Child used teeth to puncture foil top and then used fingers to tear the foil.
9 Male 51 n/a Child punctured with finger to open the first cartridge and then used his teeth to open the five others.
12* Male 50 n/a Child was given a cartridge with reinforced tape for the second five minutes. Child peeled the the reinforced tape and then used teeth.
17 Male 48 n/a Child used teeth to puncture foil top and then used fingers to tear the foil.
18 Male 50 n/a Child used teeth to puncture foil top and then used fingers to tear the foil.
19 Female 48 n/a Child punctured foil top with thumb.
20 Male 43 n/a Child used teeth to puncture foil top and then used fingers to tear the foil.
The Child-Resistance Screening Test with the Swiss Miss K-Cups® had a 65% pass rate.
The container passed if the child opened two or fewer cartridges. This is not an acceptable level of child-resistance for beverage products that contain pharmaceutical products, especially
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017 products containing acetaminophen or diphenhydramine. Almost all of the children who accessed the contents, used their teeth to puncture the lidding. Thus, in order to make a child resistant cartridge it can be important to have a lidding that cannot be punctured or tom by biting. One child opened the package by applying steady pressure with his thumb to puncture the foil lidding.
Thus, the lidding can also be made child resistant if it is not susceptible to being opened by pressing.
It is also interesting to note that after the children saw the demonstration and were told they could use their teeth, many more children gained access to the contents of the cartridge. Also, if a child was able to open one cartridge, he or she was generally able to open the 0 remaining cartridges very quickly. Therefore, in order to make the cartridge child-resistant, it may be necessary to make the cartridge tear resistant.
Although the cartridges which were reinforced with packing tape were not child resistant, it did take the children longer to access the contents of these cartridges. Thus, if the heat seal was stronger, the child-resistant properties of the package may be improved.
Although the two children who received cartridges with reinforced tops were able to access the contents, they were not able to access the contents by biting or otherwise puncturing the reinforced tape. Instead, they were able to separate the reinforced tape from the K-Cup® lidding by pealing. Therefore, if the packing tape was more securely adhered to the lidding, for instance in a laminate structure, a sufficient level of child-resistance could be achieved.
Ό
Example 2
Example 2 shows the results from the second Child-Resistant Screening Test utilizing laminate lidding structure believed to be superior to those tested in Example 1. The procedures for the Child-Resistant Screening Test were followed as described above. This example used the 25 same base as Example 1; however the lidding had a different laminate structure. The laminate had an outer layer, a second layer, and an inner layer. The outer layer was 12 pm PET, the second layer was 9 pm foil, and the inner layer was 25 pm LLDPE. The outer layer was connected to the second layer with adhesive and the second layer was connected to the inner layer with adhesive. The cartridges were filled with Ovaltine® (batch number #401158801G). 30 Table 3, below, shows how many cartridges were opened and how long it took to open each one.
Table 4, describes the method used for each child who opened three or more cartridges during the Child-Resistant Screening Test. Age groups are as follows: A=42-44 months, B=45-48 months, and C=49-51 months old.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
Table 3
Gender Age (group) First 5 min test period Time to open cartridge (min) Second 5 min test period Time to open cartridge (min)
1 2 3 4 5 6 1 2 3 4 5 6
1 Female A
2 Male B
3 Male A
4 Male B 4:40
5 Female B
6 Female B
7 Female C 6:00 8:02
8 Male C
9 Female B 6:01 7:12 7:16
10 Female C 7:16 7:45 8:22
11 Male C 1:40 1:54 2:31
12** Male C 7:34 8:01 9:05
13 Female C
14 Male C
15 Female C
16 Female C
17 Female B
18 Female A
19 Male A
20 Female A 7:20 8:43 9:21
**Child found a way to access the product using an artifact of the method used to make the prototype samples for testing. It is believed, that normal manufacturing would not allow this 5 access method to be as successful.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
Table 4
Gender Age (group) Description of how cartridges were opened
9 Female B Peeled lid, poked with thumbs/finger, struck against floor
10 Female C Peeled lid, struck against floor
11 Male C Poked hard with thumb/knuckle
12** Male C Peeled lid, crushed until plastic formed small hole, banged on package, poking at thin spot in plastic (artifact of prototyping)
20 Female A Peeled lid, used teeth after demo
This Child-Resistance Screening Test with the laminate lidding of Example 2 had a 75% pass rate counting child #12 and a 80% pass rate if he was excluded. The container passed if the 5 child opened three or fewer cartridges. 75% is not an acceptable level of child-resistance (80% is the minimum level of acceptance) for beverage products that contain pharmaceutical products, especially products containing acetaminophen or diphenhydramine. Almost all of the children who accessed the contents, used their teeth or fingers to puncture the lidding. Thus, in order to make a child resistant cartridge it can be important to have a lidding that cannot be punctured or 0 tom by biting.
Example 3
Example 3 shows the results from the third Child-Resistant Screening Test utilizing new packaging component materials believed to be superior to those tested in Example 1 and 5 Example 2. The procedures for the Child-Resistant Screening Test were followed as described above. The trial used the same base as Example 1; however the lidding had a different laminate structure. The laminate had an outer layer, a second layer, and an inner layer. The outer layer was 23 pm PET, the second layer was 18 pm foil, and the inner layer was 25 pm LLDPE. The outer layer was connected to the second layer with adhesive and the second layer was connected to the 20 inner layer with adhesive. The cartridges were filled with Ovaltine® (batch number #401158801G). Table 5, below, shows how many cartridges were opened and how long it took to open each one. Table 6, describes the method used for each child who opened three or more cartridges during the Child-Resistant Screening Test. Age groups are as follows: A=42-44 months, B=45-48 months, and C=49-51 months old.
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017
Table 5
Gender Age (group) First 5 min test period Time to open cartridge (min) Second 5 min test period Time to open cartridge (min)
1 2 3 4 5 6 1 2 3 4 5 6
1 Male B
2 Male B
3 Female A
4 Male A
5 Male B
6 Female A
7 Female B
8 Male B
9 Male B 6:27 6:53 7:02
10 Female B 9:58
11 Female C
12 Male B
13 Male C
14 Female C 7:58
15 Male C
16 Female C 2:17 2:40 3:09
17 Female C
18 Male A
19 Male B
20 Female B
Table 6
Gender Age (mo) Description of how cartridges were opened
9 Male B Peeled lid, used teeth after demo to access all three containers
16 Female C No detail given except required very little effort
This Child-Resistance Screening Test with the laminate lidding of Example 3 had a 90% pass rate. The container passed if the child opened three or fewer cartridges. 90% is an acceptable level of child-resistance (80% is the minimum level of acceptance) for beverage products which
WO 2015/081145
PCT/US2014/067518
2017245390 12 Oct 2017 contain pharmaceutical products, especially products containing acetaminophen or diphenhydramine.
The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such 5 dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”
Every document cited herein, including any cross referenced or related patent or application and any patent application or patent to which this application claims priority or 0 benefit thereof, is hereby incorporated herein by reference in its entirety unless expressly excluded or otherwise limited. The citation of any document is not an admission that it is prior art with respect to any invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches, suggests or discloses any such invention. Further, to the extent that any meaning or definition of a term in this document conflicts with any 5 meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is Ό therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.

Claims (5)

  1. The claims defining the invention are as follows:
    1. A child-resistant multi-layer laminate lidding adapted for a cartridge comprising:
    a. a PET outer layer;
    b. a foil second layer; and
    c. a LLDPE inner layer;
    wherein at least the PET outer layer of the lidding is made of a tear resistant material that is sufficient to prevent 70% of children from accessing the contents of three or more cartridges by puncturing the lidding during a Child-Resistant Screening Test, as herein defined, and wherein the lidding is penetrable by a needle or other penetrator of an automatic brewing machine.
  2. 2. The child-resistant lidding of claim 1 wherein the lidding further comprises reinforced strands.
  3. 3. The child-resistant lidding of claim 1 or claim 2 wherein the second layer comprises aluminum foil.
  4. 4. The child-resistant lidding of any one of claims 1 to 3 wherein the lidding further comprises a weakened area.
  5. 5. The child-resistant lidding of any one of claims 1 to 4 wherein the lidding comprises a final moisture vapor transmission rate of about 2 x 10‘5 to about 2 x 10‘3 g/cartridge/day.
AU2017245390A 2013-11-27 2017-10-12 Beverage cartridge containing pharmaceutical actives Ceased AU2017245390B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017245390A AU2017245390B2 (en) 2013-11-27 2017-10-12 Beverage cartridge containing pharmaceutical actives

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361909556P 2013-11-27 2013-11-27
US61/909,556 2013-11-27
AU2014354787A AU2014354787B2 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives
PCT/US2014/067518 WO2015081145A1 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives
AU2017245390A AU2017245390B2 (en) 2013-11-27 2017-10-12 Beverage cartridge containing pharmaceutical actives

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2014354787A Division AU2014354787B2 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives

Publications (2)

Publication Number Publication Date
AU2017245390A1 AU2017245390A1 (en) 2017-11-02
AU2017245390B2 true AU2017245390B2 (en) 2019-03-07

Family

ID=52014447

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2014354787A Ceased AU2014354787B2 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives
AU2017245390A Ceased AU2017245390B2 (en) 2013-11-27 2017-10-12 Beverage cartridge containing pharmaceutical actives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2014354787A Ceased AU2014354787B2 (en) 2013-11-27 2014-11-26 Beverage cartridge containing pharmaceutical actives

Country Status (7)

Country Link
EP (1) EP3073981B1 (en)
CN (1) CN105848625B (en)
AU (2) AU2014354787B2 (en)
CA (1) CA2929863A1 (en)
MX (1) MX2016006449A (en)
RU (1) RU2669392C1 (en)
WO (1) WO2015081145A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015011169B4 (en) * 2015-09-01 2018-12-20 LigaLife GmbH & Co. KG Capsule for a production of a liquid food
DE102015115250A1 (en) * 2015-09-10 2017-03-16 Pester Pac Automation Gmbh Use of a packaging
US20170280929A1 (en) 2016-03-30 2017-10-05 Eco 2, Llc Descaling device for a beverage machine and method of descaling a beverage machine
IT201600111266A1 (en) * 2016-11-04 2018-05-04 Safta Spa CAPSULE, MANUFACTURING METHOD, MULTILAYER FILM
US10881582B2 (en) * 2018-06-11 2021-01-05 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Individual dose pack
WO2020039411A2 (en) * 2019-09-28 2020-02-27 Famatek Gmbh Capsule comprising a main and a supplemental precursor ingredient, method for production of said capsule and method for preparing a beverage
GR1010650B (en) * 2023-01-17 2024-03-12 Ιουλια Κλεωνος Τσετη Pharmaceutical water-soluble paraketamol composition contained in a hermetically closed container for the preparation of beverages

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2154101A1 (en) * 2004-02-18 2010-02-17 MDS Global Holding LTD. Dispensing of a substance
US20110151075A1 (en) * 2009-12-18 2011-06-23 Green Mountain Coffee Roasters, Inc. Beverage formation apparatus and method using sonic energy
EP2551216A1 (en) * 2011-07-26 2013-01-30 Cavonic GmbH Packaging container, production method and production device
US20130129870A1 (en) * 2010-02-01 2013-05-23 Green Mountain Coffee Roasters, Inc. Method and apparatus for cartridge-based carbonation of beverages
WO2013144838A1 (en) * 2012-03-26 2013-10-03 Sarong Societa' Per Azioni Capsule for beverage and method for manufacturing said capsule

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2754376B1 (en) * 2010-02-01 2015-03-25 Keurig Green Mountain, Inc. Method and apparatus for cartridge-based carbonation of beverages
WO2014127467A1 (en) * 2013-02-25 2014-08-28 2266170 Ontario Inc. Single serve capsule for improved extraction efficiency and flavor retention

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2154101A1 (en) * 2004-02-18 2010-02-17 MDS Global Holding LTD. Dispensing of a substance
US20110151075A1 (en) * 2009-12-18 2011-06-23 Green Mountain Coffee Roasters, Inc. Beverage formation apparatus and method using sonic energy
US20130129870A1 (en) * 2010-02-01 2013-05-23 Green Mountain Coffee Roasters, Inc. Method and apparatus for cartridge-based carbonation of beverages
EP2551216A1 (en) * 2011-07-26 2013-01-30 Cavonic GmbH Packaging container, production method and production device
WO2013144838A1 (en) * 2012-03-26 2013-10-03 Sarong Societa' Per Azioni Capsule for beverage and method for manufacturing said capsule

Also Published As

Publication number Publication date
CA2929863A1 (en) 2015-06-04
AU2014354787A1 (en) 2016-05-19
MX2016006449A (en) 2016-07-19
RU2016118811A (en) 2017-12-28
AU2014354787B2 (en) 2017-08-10
AU2017245390A1 (en) 2017-11-02
EP3073981A1 (en) 2016-10-05
CN105848625B (en) 2019-07-09
RU2669392C1 (en) 2018-10-11
WO2015081145A1 (en) 2015-06-04
EP3073981B1 (en) 2019-07-24
CN105848625A (en) 2016-08-10

Similar Documents

Publication Publication Date Title
US9938075B2 (en) Beverage cartridge containing pharmaceutical actives
AU2017245390B2 (en) Beverage cartridge containing pharmaceutical actives
US9744100B2 (en) Child-resistant blister package
US5511665A (en) Child-resistant package
JP5866304B2 (en) Opening system for medical blister package
JP2009233334A (en) Tearable package for medicament and method
Lockhart et al. Packaging of pharmaceuticals and healthcare products
CN112334118A (en) Individual dose package
MX2010013298A (en) Package with enclosure for dispensing doses of a medicament.
EP2911948B1 (en) Sachet for a liquid medication
CN101293582B (en) Safe type bubble cap package
US20230053278A1 (en) Pharmacy assembly machine and packaging for customised polypills, and customised antipsychotic combinations for improved compliance
EA012345B1 (en) Bend and peel tablet package
US7802682B2 (en) Systems for increasing compliance with a medicament treatment regime
WO2024118700A1 (en) An individual dose pod

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired